Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates Daniel Zimpfer, MD, Philipp Zrunek, MS, Wilfried Roethy, MD, Martin Czerny, MD, Heinz Schima, PhD, Leopold Huber, PhD, Michael Grimm, MD, Angela Rajek, MD, Ernst Wolner, MD, PhD, Georg Wieselthaler, MD The Journal of Thoracic and Cardiovascular Surgery Volume 133, Issue 3, Pages 689-695 (March 2007) DOI: 10.1016/j.jtcvs.2006.08.104 Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Pharmacologic testing: decision-making tree. TX, Transplant; PVR, pulmonary vascular resistance; WU, Wood units; PG, prostaglandin; NO, nitric oxide; LVAD, left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 689-695DOI: (10.1016/j.jtcvs.2006.08.104) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Kaplan–Meier curve displaying overall survival after LVAD implantation. The Journal of Thoracic and Cardiovascular Surgery 2007 133, 689-695DOI: (10.1016/j.jtcvs.2006.08.104) Copyright © 2007 The American Association for Thoracic Surgery Terms and Conditions